This story was originally published July 5.
Genome British Columbia and the BC Cancer Foundation have formed a partnership to develop a genomic test to determine whether acute myeloid leukemia patients should receive chemotherapy or stem cell transplantation.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
